+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Legionella Testing Market Size, Share, & Trends Analysis Report by Type (Water Testing, IVD Testing), End Use (Microbial Culture, Direct Fluorescent Antibody (DFA) Stain, PCR, Others), Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 5893144
The Legionella Testing Market was valued at USD 343.2 Million in 2024, and is projected to reach USD 547.4 Million by 2030, rising at a CAGR of 8.20%. According to the World Health Organization (WHO), nearly 10 to 15 new cases per million population are identified every year in Europe, Australia, and the U.S.

The growing inclination towards timely legionella testing can be attributed to advantages such as speedy recovery and improved patient outcome. Additionally, integrating legionella testing methods with advanced diagnostic technologies such as PCR and point-of-care testing are expected to fuel growth of this market in the forecast period.

Government-sponsored initiatives, including legionella testing programs, awareness campaigns, and water safety regulations, are estimated to increase the detection and management of legionella cases globally. For instance, in Europe, stringent regulations mandate regular Legionella testing in water systems, which is expected to boost the demand for advanced Legionella testing methods.

Legionella Testing Market Report Highlights

  • Europe dominated the global legionella testing market with over 39.0% share in 2024 owing to factors such as increasing awareness regarding legionellosis, sophisticated healthcare systems, public health protection initiatives, and mandatory testing regulations in countries such as the UK and Germany.
  • The IVD testing segment is expected to grow at a significant CAGR over the forecast period.
  • Based on end use, the PCR segment dominated market with revenue share of 37.7% in 2024. PCR enables the precise and rapid detection of bacteria through its high sensitivity and quick turnaround time.
  • Increasing legionella outbreaks recorded in numerous regions driven by factors such as demography, environmental factors and others are expected to drive demand.
  • Significantly enhanced healthcare systems, growing awareness regarding timely interventions, and government initiatives associated with public health are likely to add lucrative growth opportunities to this industry over forecast period.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional Scope
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End Use outlook
2.2.3. Regional out
2.3. Competitive Insights
Chapter 3. Legionella Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Legionella Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Legionella Testing: Type Estimates & Trend Analysis
4.1. Type Segment Dashboard
4.2. Legionella Testing Market: Type Movement Analysis
4.3. Global Legionella Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Water Testing
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. IVD Testing
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Legionella Testing Market: End Use Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Legionella Testing Market: Application Movement Analysis
5.3. Global Legionella Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Microbial culture
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Direct Fluorescent Antibody (DFA) Stain
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. PCR
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Legionella Testing Market: Regional Estimates & Trend Analysis
6.1. Regional Segment Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Legionella Testing market by Region: Key Takeaways
6.4. North America
6.4.1. U.S
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. U.K.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.K. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Germany
6.5.2.5. Key country dynamics
6.5.2.6. Regulatory framework/ reimbursement structure
6.5.2.7. Competitive scenario
6.5.2.8. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Norway
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Aregentina
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.8. MEA
1.1.2. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/ reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Beckman Coulter, Inc
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. BD
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Bio-Rad Laboratories, Inc.
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. BIOMÉRIEUX
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Eiken Chemical Co., Ltd.
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Hologic, Inc.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Pro Lab Diagnostics Inc.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. QIAGEN
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. F. Hoffmann-La Roche Ltd.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Takara Bio Inc.
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Thermo Fisher Scientific Inc.
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
List of Tables
Table 1. List of abbreviations
Table 2. Global legionella testing market, by region, 2018-2030 (USD Million)
Table 3. Global legionella testing market, by type, 2018-2030 (USD Million)
Table 4. Global legionella testing market, by end use, 2018-2030 (USD Million)
Table 5. North America legionella testing market, by country, 2018-2030 (USD Million)
Table 6. North America legionella testing market, by type, 2018-2030 (USD Million)
Table 7. North America legionella testing market, by end use, 2018-2030 (USD Million)
Table 8. U.S. legionella testing market, by type, 2018-2030 (USD Million)
Table 9. U.S. legionella testing market, by end use, 2018-2030 (USD Million)
Table 10. Canada legionella testing market, by type, 2018-2030 (USD Million)
Table 11. Canada legionella testing market, by end use, 2018-2030 (USD Million)
Table 12. Mexico legionella testing market, by type, 2018-2030 (USD Million)
Table 13. Mexico legionella testing market, by end use, 2018-2030 (USD Million)
Table 14. Europe legionella testing market, by country, 2018-2030 (USD Million)
Table 15. Europe legionella testing market, by type, 2018-2030 (USD Million)
Table 16. Europe legionella testing market, by end use, 2018-2030 (USD Million)
Table 17. Germany legionella testing market, by type, 2018-2030 (USD Million)
Table 18. Germany legionella testing market, by end use, 2018-2030 (USD Million)
Table 19. UK legionella testing market, by type, 2018-2030 (USD Million)
Table 20. UK legionella testing market, by end use, 2018-2030 (USD Million)
Table 21. France legionella testing market, by type, 2018-2030 (USD Million)
Table 22. France legionella testing market, by end use, 2018-2030 (USD Million)
Table 23. Italy legionella testing market, by type, 2018-2030 (USD Million)
Table 24. Italy legionella testing market, by end use, 2018-2030 (USD Million)
Table 25. Spain legionella testing market, by type, 2018-2030 (USD Million)
Table 26. Spain legionella testing market, by end use, 2018-2030 (USD Million)
Table 27. Denmark legionella testing market, by type, 2018-2030 (USD Million)
Table 28. Denmark legionella testing market, by end use, 2018-2030 (USD Million)
Table 29. Sweden legionella testing market, by type, 2018-2030 (USD Million)
Table 30. Sweden legionella testing market, by end use, 2018-2030 (USD Million)
Table 31. Norway legionella testing market, by type, 2018-2030 (USD Million)
Table 32. Norway legionella testing market, by end use, 2018-2030 (USD Million)
Table 33. Asia Pacific legionella testing market, by country, 2018-2030 (USD Million)
Table 34. Asia Pacific legionella testing market, by type, 2018-2030 (USD Million)
Table 35. Asia Pacific legionella testing market, by end use, 2018-2030 (USD Million)
Table 36. China legionella testing market, by type, 2018-2030 (USD Million)
Table 37. China legionella testing market, by end use, 2018-2030 (USD Million)
Table 38. Japan legionella testing market, by type, 2018-2030 (USD Million)
Table 39. Japan legionella testing market, by end use, 2018-2030 (USD Million)
Table 40. India legionella testing market, by type, 2018-2030 (USD Million)
Table 41. India legionella testing market, by end use, 2018-2030 (USD Million)
Table 42. South Korea legionella testing market, by type, 2018-2030 (USD Million)
Table 43. South Korea legionella testing market, by end use, 2018-2030 (USD Million)
Table 44. Australia legionella testing market, by type, 2018-2030 (USD Million)
Table 45. Australia legionella testing market, by end use, 2018-2030 (USD Million)
Table 46. Thailand legionella testing market, by type, 2018-2030 (USD Million)
Table 47. Thailand legionella testing market, by end use, 2018-2030 (USD Million)
Table 48. Latin America legionella testing market, by country, 2018-2030 (USD Million)
Table 49. Latin America legionella testing market, by type, 2018-2030 (USD Million)
Table 50. Latin America legionella testing market, by end use, 2018-2030 (USD Million)
Table 51. Brazil legionella testing market, by type, 2018-2030 (USD Million)
Table 52. Brazil legionella testing market, by end use, 2018-2030 (USD Million)
Table 53. Argentina legionella testing market, by type, 2018-2030 (USD Million)
Table 54. Argentina legionella testing market, by end use, 2018-2030 (USD Million)
Table 55. MEA legionella testing market, by country, 2018-2030 (USD Million)
Table 56. MEA legionella testing market, by type, 2018-2030 (USD Million)
Table 57. MEA legionella testing market, by end use, 2018-2030 (USD Million)
Table 58. South Africa legionella testing market, by type, 2018-2030 (USD Million)
Table 59. South Africa legionella testing market, by end use, 2018-2030 (USD Million)
Table 60. Saudi Arabia legionella testing market, by type, 2018-2030 (USD Million)
Table 61. Saudi Arabia legionella testing market, by end use, 2018-2030 (USD Million)
Table 62. UAE legionella testing market, by type, 2018-2030 (USD Million)
Table 63. UAE legionella testing market, by end use, 2018-2030 (USD Million)
Table 64. Kuwait legionella testing market, by type, 2018-2030 (USD Million)
Table 65. Kuwait legionella testing market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Legionella testing market: market outlook
Figure 10 Legionella testing competitive insights
Figure 11 Parent market outlook
Figure 12 Related/ancillary market outlook
Figure 13 Penetration and growth prospect mapping
Figure 14 Industry value chain analysis
Figure 15 Legionella testing market driver impact
Figure 16 Legionella testing market restraint impact
Figure 17 Legionella testing market strategic initiatives analysis
Figure 18 Legionella testing market: type movement analysis
Figure 19 Legionella testing market: type outlook and key takeaways
Figure 20 Water testing market estimates and forecast, 2018-2030
Figure 21 IVD testing market estimates and forecast, 2018-2030
Figure 22 Legionella testing market: End use movement analysis
Figure 23 Legionella testing market: End use outlook and key takeaways
Figure 24 Microbial culture market estimates and forecasts, 2018-2030
Figure 25 Direct Fluorescent Antibody (DFA) Stain market estimates and forecasts,2018-2030
Figure 26 PCR market estimates and forecasts,2018-2030
Figure 27 Others market estimates and forecasts,2018-2030
Figure 28 Global Legionella testing market: Regional movement analysis
Figure 29 Global Legionella testing market: Regional outlook and key takeaways
Figure 30 North America market estimates and forecasts, 2018-2030
Figure 31 US market estimates and forecasts, 2018-2030
Figure 32 Canada market estimates and forecasts, 2018-2030
Figure 33 Mexico market estimates and forecasts, 2018-2030
Figure 34 Europe market estimates and forecasts, 2018-2030
Figure 35 UK market estimates and forecasts, 2018-2030
Figure 36 Germany market estimates and forecasts, 2018-2030
Figure 37 France market estimates and forecasts, 2018-2030
Figure 38 Italy market estimates and forecasts, 2018-2030
Figure 39 Spain market estimates and forecasts, 2018-2030
Figure 40 Denmark market estimates and forecasts, 2018-2030
Figure 41 Sweden market estimates and forecasts, 2018-2030
Figure 42 Norway market estimates and forecasts, 2018-2030
Figure 43 Asia Pacific market estimates and forecasts, 2018-2030
Figure 44 China market estimates and forecasts, 2018-2030
Figure 45 Japan market estimates and forecasts, 2018-2030
Figure 46 India market estimates and forecasts, 2018-2030
Figure 47 Thailand market estimates and forecasts, 2018-2030
Figure 48 South Korea market estimates and forecasts, 2018-2030
Figure 49 Australia market estimates and forecasts, 2018-2030
Figure 50 Latin America market estimates and forecasts, 2018-2030
Figure 51 Brazil market estimates and forecasts, 2018-2030
Figure 52 Argentina market estimates and forecasts, 2018-2030
Figure 53 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 54 South Africa market estimates and forecasts, 2018-2030
Figure 55 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 56 UAE market estimates and forecasts, 2018-2030
Figure 57 Kuwait market estimates and forecasts, 2018-2030

Companies Mentioned

The companies profiled in this Legionella Testing market report include:
  • Abbott
  • Beckman Coulter, Inc. (Danaher Corporation)
  • BD
  • Bio-Rad Laboratories, Inc.
  • BIOMÉRIEUX
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc
  • Pro Lab Diagnostics Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Table Information